A detailed history of Alta Advisers LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Alta Advisers LTD holds 1,000 shares of MRNA stock, worth $115,950. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,000 -0.0%
Holding current value
$115,950
Previous $99,000 7.07%
% of portfolio
0.05%
Previous 0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 28, 2022

BUY
$118.07 - $194.18 $118,070 - $194,180
1,000 New
1,000 $118,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Alta Advisers LTD Portfolio

Follow Alta Advisers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alta Advisers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Alta Advisers LTD with notifications on news.